Familial Transthyretin Cardiac Amyloidosis
1 clinical trials · Condition
◉ Watch Familial Transthyretin Cardiac Amyloidosis
| Record | Firm | Date |
|---|---|---|
| ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) (NCT02319005) | Alnylam Pharmaceuticals | 2014-12-01 |
Track Familial Transthyretin Cardiac Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.